Cargando…
Survey of Japanese Orphan Drug Program: Factors Related to Successful Marketing Approval
The basic components of regulatory and supporting policies for orphan drug development appear similar between the United States and Japan, but drugs designated as orphan drugs have been different between the 2 countries. The probabilities of development success (ie, marketing approval) in designated...
Autores principales: | Harada, Kenji, Toriyabe, Kazuki, Ono, Shunsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972571/ https://www.ncbi.nlm.nih.gov/pubmed/31364772 http://dx.doi.org/10.1002/jcph.1501 |
Ejemplares similares
-
Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010) -
Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010) -
China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020) -
391 An Investigation on the Activity of Repurposing Already Marketed Drugs for New Indications from 2015 to 2021.
por: Wu, Wenchao, et al.
Publicado: (2023) -
397 Regulations and Marketing of Energy Drinks in the United States: A Survey of University Student Beliefs about Caffeine Consumption
por: Chung, Christian, et al.
Publicado: (2023)